ALPINE GROUP PARTNERS, LLC.

Lobbying for AMGEN

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 19, 2026

Lobbying activity 3

Medicare/Medicaid

Proposals related to drug pricing, drug price transparency, PBMs, the 340B program Implementation of the Inflation Reduction Act

Taxation/Internal Revenue Code

International tax developments

Trade (domestic/foreign)

Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.